| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-10 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.2 | 5e-09 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-08 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-07 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-07 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-07 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-07 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-07 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.15 | 5e-07 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-07 |